glutathione mutations in sclc patients vivo functional screens reveal KEAP1 loss as a driver of chemoresistance in small cell lung cancer Antibody-drug conjugates: A new twist
Antibody drug conjugates: A new twist to overcome EGFR TKIs resistance in non small cell lung cancer ScienceDirect Inhibiting the system xC glutathione axis selectively targets cancers with mutant p53 accumulation Nature Communications Tumor suppressor genes and KRAS G12C inhibitor resistance in non small cell lung cancer: iScience glutathione mutations in sclc patients Role of Cancer: From Mechanisms to Therapies Deep Clustering Based Metabolic Stratification of
Pay in 4 interest-free payments of $6.94 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Aug 7 - Aug 12



